XM does not provide services to residents of the United States of America.

Deals of the day-Mergers and acquisitions



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Deals of the day-Mergers and acquisitions</title></head><body>

Adds: ConocoPhillips, Halozyme Therapeutics, Honeywell, Advent International

Nov 22 (Reuters) -The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Friday:


** U.S. shale oil producer ConocoPhillips COP.N said it has completed the $22.5 billion deal to acquire smaller peer Marathon Oil MRO.N. nL4N3MT110

** Halozyme Therapeutics HALO.O said it had withdrawn its proposal to acquire Evotec SE EVTG.DE for 2 billion euros ($2.09 billion) as the German drug developer was unwilling to engage in discussions. nL4N3MT0ZF

** Honeywell HON.O will sell its personal protective equipment business to Protective Industrial Products for about $1.33 billion in cash, it said, further streamlining its business. nL4N3MT0VW

** U.S. private equity firm Advent International has signed a deal to sell Indian packaging company Manjushree Technopack to PAG for an enterprise value of close to $1 billion, two sources with direct knowledge said. nL1N3MT0EO


** U.S. satellite TV provider DirecTV said on Thursday it had terminated its agreement to acquire Echostar's SATS.O satellite television business, which includes rival Dish TV, over a failed debt-exchange offer. nL4N3MT04O


** Alimentation Couche-Tard ATD.TO is not considering a hostile takeover bid for Japan's Seven & i 3382.T, the Nikkei business daily quoted the Canadian suitor's chairman and co-founder, Alain Bouchard, as saying. nL6N3MT01L


(Compiled by Rajarshi Roy and Pooja Menon in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.